Reliance Global Group, Inc. (EZRA) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Reliance Global Group, Inc., a Florida corporation, on February 9, 2026, reporting events occurring on February 6, 2026. The filing concerns the Company's ongoing At-The-Market (ATM) equity offering program.
Key Financial Metrics and Offering Details
- Offering Capacity: The Company filed Amendment No. 3 to its prospectus supplement to offer and sell shares of common stock with an aggregate offering price of up to $1,764,443.
- Recent Sales: During the 12 calendar month period ending February 6, 2026, the Company has previously offered and sold $2,343,660 of common stock under Form S-3 General Instruction I.B.6.
- Securities: Common Stock (Symbol: EZRA) and Series A Warrants (Symbol: RELIW) are registered on The NASDAQ Capital Market.
- Financial Statements: This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. It is a procedural filing regarding a securities offering.
Material Changes
The primary material change is the filing of Amendment No. 3 to the prospectus supplement dated August 13, 2025. This amendment updates the registration statement (File No. 333-275190) and the ATM Prospectus to reflect the current offering capacity and incorporates prior amendments filed in September and December 2025.
Outlook, Risks, and Management Commentary
The filing indicates the Company is actively utilizing its ATM Agreement with H.C. Wainwright & Co., LLC to raise capital. No specific forward-looking guidance, risk factors, or management commentary regarding operational performance is included in this specific document. The filing notes that Amendment No. 3 must be read in conjunction with the ATM Prospectus and is not complete without it.
Key Facts for Investor Verification
- Verify the current share price and dilution impact of the remaining $1,764,443 offering capacity.
- Review the full ATM Prospectus and prior amendments (filed Sept 18, 2025, and Dec 15, 2025) for detailed use of proceeds and risk factors.
- Confirm the total number of shares sold to date against the $2,343,660 reported in the prior 12-month period.
- Check the Company's most recent 10-Q or 10-K for actual financial performance metrics, as this 8-K contains none.